论文部分内容阅读
1980年以来,作者已将持续性不卧床腹膜透析(CAPD)列为晚期肾衰患者的首选治疗。本文报告42例用CAPD治疗的肾移植结果,其中29例接受CAPD作为首选治疗,并与血液透析(HD)组进行了比较。作者将CAPD治疗行肾移植的42例与用HD治疗作肾移植的55例作了对比。移植前将接受CAPD的分为两组:长期组21例,用CAPD>26周(平均64周、SD35周);短期组21例,用CAPD<26周(平均11周,SD8周)。免疫抑制药物:1983年7月前,全部患者均用硫唑嘌呤加小剂量强地松龙,其后改用环孢素A加小剂量强地松龙。
Since 1980, the authors have included continuous ambulatory peritoneal dialysis (CAPD) as the treatment of choice in patients with advanced renal failure. In this paper, we report the results of 42 renal transplant patients treated with CAPD. Of these, 29 received CAPD as the primary treatment and were compared with the hemodialysis (HD) group. The authors compared CAPD-treated kidney transplant in 42 patients with HD-treated kidney transplant in 55 patients. CAPD was divided into two groups before transplantation: 21 patients in the long-term group with CAPD> 26 weeks (mean 64 weeks, SD 35 weeks); 21 patients in the short-term group with CAPD <26 weeks (mean 11 weeks, SD 8 weeks). Immunosuppressive drugs: Before July 1983, all patients were treated with azathioprine plus a small dose of prednisolone, followed by cyclosporin A plus a small dose of prednisolone.